Leukemia & Lymphoma, Volume 65, Issue 4 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 65, Issue 4 (2024)

See all volumes and issues
Volume 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Review Articles

Review Article
The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors – an overview and update
Ayoma D. Attygalle, John K. C. Chan, Sarah E. Coupland, Ming-Qing Du, Judith A. Ferry, Daphne de Jong, Dita Gratzinger, Megan S. Lim, Kikkeri N. Naresh, Alina Nicolae, German Ott, Andreas Rosenwald, Anna Schuh, Reiner Siebert & on behalf of the WHO 5th Edition Classification Project
Pages: 413-429
Published online: 08 Jan 2024
AbstractforThe 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors – an overview and update | Full Text | References | PDF (1.9 MB) | EPUB
  • 406 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials
Suheil Albert Atallah-Yunes, Arushi Khurana & Matthew Maurer
Pages: 430-439
Published online: 05 Jan 2024
AbstractforChallenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials | Full Text | References | PDF (677.3 KB) | EPUB
  • 215 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Leveraging CD19CAR T cells early in the treatment of older patients with B-ALL: are we there yet?
Ibrahim Aldoss, Mary Caroline Clark, Xiuli Wang & Stephen Joel Forman
Pages: 440-448
Published online: 05 Jan 2024
AbstractforLeveraging CD19CAR T cells early in the treatment of older patients with B-ALL: are we there yet? | Full Text | References | PDF (912.9 KB) | EPUB
  • 181 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Articles

Article
Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning
Mehdi Parviz, Rudi Agius, Emelie Curovic Rotbain, Noomi Vainer, Kathrine Aarup & Carsten U. Niemann
Pages: 449-459
Published online: 05 Jan 2024
AbstractforIdentifying CLL patients at high risk of atrial fibrillation on treatment using machine learning | Full Text | References | PDF (2.9 MB) | EPUB | Supplemental
  • 236 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies
Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, Chiara Rusconi, Andrea Rossi, Alessandra Romano, Caterina Patti, Corrado Schiavotto, Roberto Sorasio, Vincenzo Marasco, Laura Lissandrini, Davide Rapezzi, Daniela Gottardi, Federica Cocito, Antonio Mulè, Salvatore Leotta, Guido Gini, Marco Sorio, Enrico Derenzini, Alessandro Rambaldi, Vincenzo Bagnardi & Corrado Tarella
Pages: 460-471
Published online: 02 Jan 2024
AbstractforHigh-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 135 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
The prognostic value of CD8+ CTLs, CD163+ TAMs, and PDL1 expression in the tumor microenvironment of primary central nervous system lymphoma
Qiqi Jin, Haoyun Jiang, Ningning Yue, Litian Zhang, Cuicui Li, Chi Dong, Pengyun Zeng, Lingling Yue & Chongyang Wu
Pages: 472-480
Published online: 10 Jan 2024
AbstractforThe prognostic value of CD8+ CTLs, CD163+ TAMs, and PDL1 expression in the tumor microenvironment of primary central nervous system lymphoma | Full Text | References | PDF (3.6 MB) | EPUB
  • 80 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison
Katja Weisel, Meletios A. Dimopoulos, Meral Beksac, Xavier Leleu, Joshua Richter, Bart Heeg, Sachin Patel, Istvan Majer, Ian McFadden & Joseph Mikhael
Pages: 481-492
Published online: 12 Feb 2024
AbstractforCarfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 1571 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation
Muhammad Umair Mushtaq, Moazzam Shahzad, Muhammad K. Amin, Forat Lutfi, Shaun DeJarnette, Joe S. Al-Ramahi, Kevin Li, Nausheen Ahmed, Rajat Bansal, Haitham Abdelhakim, Leyla Shune, Al-Ola Abdallah, Sunil H. Abhyankar, Joseph P. McGuirk & Anurag K. Singh
Pages: 493-502
Published online: 02 Jan 2024
AbstractforOutcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation | Full Text | References | PDF (1.2 MB) | EPUB
  • 191 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies
Eytan M. Stein, Amir T. Fathi, Wael A. Harb, Gozde Colak, Andrea Fusco & James K. Mangan
Pages: 503-510
Published online: 23 Jan 2024
AbstractforResults from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 1142 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Letters to the Editor

Letter to the Editor
Characteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin (NPM1) gene mutation subtypes: a single-center experience and review of the literature
Martina Mutti, Stefano Cordella, Angelica Parisotto, Francesca Bettelli, Monica Morselli, Angela Cuoghi, Paola Bresciani, Andrea Messerotti, Andrea Gilioli, Valeria Pioli, Davide Giusti, Elisabetta Colaci, Luca Cassanelli, Ambra Paolini, Silvia Martinelli, Rossana Maffei, Giovanni Riva, Vincenzo Nasillo, Mario Sarti, Tommaso Trenti, Patrizia Comoli, Enrico Tagliafico, Rossella Manfredini, Albino Eccher, Ivana Lagreca, Patrizia Barozzi, Leonardo Potenza, Roberto Marasca, Anna Candoni, Mario Luppi & Fabio Forghieri
Pages: 511-515
Published online: 19 Dec 2023
First Page PreviewforCharacteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin (NPM1) gene mutation subtypes: a single-center experience and review of the literature | Full Text | References | PDF (499.3 KB) | EPUB | Supplemental
  • 127 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Prevalence and factors of polypharmacy among disease-free survivors of adults after allogeneic hematopoietic cell transplantation
Eita Miyashita, Nozomi Sugihara, Miho Tanaka, Hiromi Iwasaki, Maki Monna-Oiwa, Masamichi Isobe, Seiko Kato, Satoshi Takahashi, Yasuhito Nannya, Yukari Tsuru & Takaaki Konuma
Pages: 516-520
Published online: 27 Dec 2023
First Page PreviewforPrevalence and factors of polypharmacy among disease-free survivors of adults after allogeneic hematopoietic cell transplantation | Full Text | References | PDF (910.6 KB) | EPUB | Supplemental
  • 61 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Drug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene
Jianli Wang, Lei Xu, Yuqing Li, Jun Wang, Yangliu Shao, Weifeng Lai, Jun Yong, Ling Zhao, Xuemin Wei, Chunji Gao, Daihong Liu, Xiaoning Gao & Yongqing Zhang
Pages: 521-525
Published online: 29 Dec 2023
First Page PreviewforDrug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene | Full Text | References | PDF (2.8 MB) | EPUB | Supplemental
  • 88 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
The successful management of acute promyelocytic leukemia during pregnancy: a case report
Brittany Salter, James Michael Radford, Tobias Berg & Brian Leber
Pages: 526-529
Published online: 19 Dec 2023
First Page PreviewforThe successful management of acute promyelocytic leukemia during pregnancy: a case report | Full Text | References | PDF (397.2 KB) | EPUB
  • 178 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
A retrospective analysis of factors impacting survival in United States military veterans with multiple myeloma
Sharmeen Mahmood, Pankaj Gupta & Helen Ma
Pages: 530-533
Published online: 26 Dec 2023
First Page PreviewforA retrospective analysis of factors impacting survival in United States military veterans with multiple myeloma | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 62 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Per-Ola Andersson, Kristina Sonnevi, Maria Ljungqvist, Birgitta Sander, Mats Jerkeman & Karin E. Smedby
Pages: 534-537
Published online: 22 Dec 2023
First Page PreviewforOutcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy | Full Text | References | PDF (765.5 KB) | EPUB | Supplemental
  • 182 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Real-world data of the use of rivaroxaban in pediatric patients with hematologic malignancies
Noémie Sultan, Marie-Claude Pelland-Marcotte, Meredith Remy, Josette Champagne, Caroline Laverdière, Rochelle Winikoff & Thai Hoa Tran
Pages: 538-540
Published online: 03 Jan 2024
First Page PreviewforReal-world data of the use of rivaroxaban in pediatric patients with hematologic malignancies | Full Text | References | PDF (294.4 KB) | EPUB | Supplemental
  • 190 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Prevalence of primary chronic lymphocytic leukemia in the United States: a cross-sectional study using the SEER database
Shangyi Fu, Zachrieh Alhaj & Danny Huynh
Pages: 541-542
Published online: 22 Jan 2024
CitationforPrevalence of primary chronic lymphocytic leukemia in the United States: a cross-sectional study using the SEER database | Full Text | References | PDF (276.8 KB) | EPUB
  • 70 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles